Clinical trial
A First-in-Human Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of MAX-40070 in Healthy Subjects
NCT05196711 is registered in ClinicalTrials.gov with Maxinovel Pty., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A First-in-Human Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of MAX-40070 in Healthy Subjects
- Lead sponsor
- Maxinovel Pty., Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- February 28, 2022
- Completion date
- November 30, 2022
- Enrollment
- 78 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.